companies: 9,734     total market cap: €100.581 T
$USD🇺🇸₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰$SGD🇸🇬
Novavax
NVAX
#4309
Rank
€1.80 B
Marketcap
🇺🇸 USA
Country
11,30 €
Share price
-0.32%
Change (1 day)
57.16%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

Revenue for Novavax (NVAX)

Revenue in 2024 (TTM): €0.72 B

According to Novavax's latest financial reports the company's current revenue (TTM) is €0.70 B. In 2023 the company made a revenue of €0.62 B a decrease over the revenue in the year 2022 that were of €1.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) €0.72 B15.5%
2023 €0.62 B-51.71%
2022 €1.29 B28.92%
2021 €1.00 B158.97%
2020 €0.38 B2240.9%
2019 €16.62 M-44.47%
2018 €29.93 M15.2%
2017 €25.98 M78.01%
2016 €14.59 M-56.04%
2015 €33.2 M31.84%
2014 €25.18 M66.37%
2013 €15.13 M-9.36%
2012 €16.7 M47.68%
2011 €11.31 M4275%
2010 €0.25 M13.88%
2009 €0.22 M-69.9%
2008 €0.75 M-14.8%
2007 €0.88 M-75.06%
2006 €3.54 M-43.09%
2005 €6.23 M5.66%
2004 €5.9 M-37.44%
2003 €9.43 M-30.56%
2002 €13.58 M-50.14%
2001 €27.25 M937.22%
2000 €2.62 M120.31%
1999 €1.19 M102.16%
1998 €0.58 M16.67%
1997 €0.5 M100%
1996 €0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
€0.14 B-79.66%🇺🇸 USA
Sarepta Therapeutics
SRPT
€1.35 B 91.77%🇺🇸 USA
Emergent BioSolutions
EBS
€0.96 B 36.90%🇺🇸 USA
BioCryst Pharmaceuticals
BCRX
€0.34 B-51.30%🇺🇸 USA
AstraZeneca
AZN
€44.33 B 6,160.56%🇬🇧 UK
Pfizer
PFE
€50.21 B 6,989.94%🇺🇸 USA
Novartis
NVS
€44.09 B 6,125.77%🇨🇭 Switzerland
NanoViricides
NNVC
N/AN/A🇺🇸 USA
GlaxoSmithKline
GSK
€35.61 B 4,928.90%🇬🇧 UK
Celldex Therapeutics
CLDX
€7.49 M-98.94%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
 CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com